Whitehawk Therapeutics In...

NASDAQ: WHWK · Real-Time Price · USD
1.74
0.09 (5.45%)
At close: Aug 22, 2025, 3:58 PM
1.74
0.00%
After-hours: Aug 22, 2025, 04:04 PM EDT

Whitehawk Therapeutics Inc Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-10.42M 27.61M -63.69M -61.69M -65.44M -68.83M -65.77M -63.41M -61.58M -61.88M -60.51M -62.59M -135.2M -118.47M -110.09M -86.08M -1.88M -5.63M
Depreciation & Amortization
167K 200K 193K 190K 187K 181K 169K 171K 139K 123K 159K 185K 202K 177K 105K 35K 8.52K 8.76K
Stock-Based Compensation
9.18M 8.93M 10.84M 12.1M 12.59M 12.8M 11.95M 11.71M 11.42M 10.6M 9.64M 8.16M 6.05M 3.85M 2.11M 762K 148K 145.65K
Other Working Capital
-1.29M 3.62M 3.02M 4.01M 5.17M 5.23M 3.62M 3.97M 6.11M 5.88M 6.03M 3.22M -5.56M -6.37M -5.93M -1.8M 2.07M 1.8M
Other Non-Cash Items
-93.17M -90.95M -10.61M -6.66M 907K -7.19M -1.21M -6.6M -8M 1.74M 2.89M 3.96M 78.07M 71.9M 73.8M 73.58M 624.37K 6.01M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.31M 2.45M 3.72M 1.92M 1.36M 5.03M -4.82M -3.2M 452K -2.12M -1.82M -473K -9.05M -9.86M 11.65M -1.56M 2.17M 1.79M
Operating Cash Flow
-95.56M -51.76M -59.55M -54.14M -50.41M -58.01M -59.66M -61.33M -57.57M -51.53M -49.64M -50.76M -59.94M -52.4M -22.42M -13.27M 1.07M 2.33M
Capital Expenditures
-926K -1.47M -1.65M -2.28M -3.19M -3.34M -3.97M -3.23M -2.24M -1.79M -444K -366K -264K -23K n/a n/a n/a n/a
Cash Acquisitions
101.36M 101.36M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 25.36M 25.36M 25.36M 25.36M n/a n/a
Purchase of Investments
-42.14M -28.84M -36.48M -50.38M -67.94M -49.03M -64.44M -147.59M -168.24M -168.24M -145.19M -48.14M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
46.6M 59.09M 63.34M 68.38M 94.44M 78.56M 100.37M 82M 40.75M 40.75M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a 51.25M 51.25M 64M 64M 12.75M 12.75M -46K -46K -203K -203K -157K -157K n/a
Investing Cash Flow
104.89M 130.15M 25.2M 15.72M 23.3M 77.43M 83.21M -4.82M -65.73M -116.53M -132.89M -48.55M 25.05M 25.13M 25.15M 25.2M -157K n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -366 194K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.41M -4.41M -4.41M -4.41M n/a n/a
Other Financial Acitivies
-5.6M -4.66M 130K 157K 82K 308K 326K 139K 72.73M 72.33M 72.62M 72.81M 142.02M 142.1M 141.8M 141.72M -1K n/a
Financial Cash Flow
94.4M 95.34M 130K 157K 82K 308K 326K 139K 72.73M 72.33M 72.62M 72.81M 142.02M 142.1M 141.8M 141.72M -1.37K 194K
Net Cash Flow
103.73M 173.72M -34.22M -38.27M -27.02M 19.73M 23.87M -66.01M -50.58M -95.74M -109.91M -26.5M 107.13M 114.83M 144.53M 153.65M 910.56K 2.53M
Free Cash Flow
-96.49M -53.23M -61.2M -56.42M -53.6M -61.35M -63.63M -64.56M -59.81M -53.33M -50.08M -51.17M -60.25M -52.47M -22.47M -13.27M 1.07M 2.33M